Individual budgets for people with incontinence: results from a 'shopping' experiment within the British National Health Service.

Health Expect

Professor, Faculty of Health Sciences, University of Southampton, SouthamptonProfessor, Department of Medical Physics, University College London, Archway Campus, Highgate Hill, LondonReader, Department of Economics, University of Surrey, Guildford, UKStatistical Consultant, Department of Mathematics, University of Surrey, Guildford, UKProfessor (Retired), Faculty of Health Sciences, University of Southampton, SouthamptonResearch Fellow, Department of Medical Physics, University College London, Archway Campus, Highgate Hill, London, UK.

Published: April 2014

AI Article Synopsis

  • Many individuals with urinary incontinence face limited options when it comes to absorbent products provided by the NHS, despite a wider range being available.
  • The study aimed to understand preferences between different disposable and washable product designs among community-dwelling adults with moderate-to-heavy incontinence, allowing them to test various designs within set budgets.
  • Results showed diverse preferences, with participants favoring pull-ups over commonly supplied inserts; many expressed willingness to 'mix-and-match' products and supplement budgets to obtain their preferred choices, suggesting that offering choice could enhance user satisfaction and resource efficiency in the NHS.

Article Abstract

Background And Context: Most people with urinary incontinence are given limited choice when provided with absorbent products through the British National Health Service (NHS), even though the available range is large.

Objective: To investigate users' preferences for four disposable designs (inserts, all-in-ones, belted/T-shaped and pull-ups) and towelling washable/reusable products, day and night.

Design: Shopping experiment.

Setting And Participants: Community-dwelling women and men in England with moderate-to-heavy urinary incontinence recruited to a larger trial.

Intervention: Participants tested each design and selected products they would prefer with a range of different budgets.

Main Outcome Measures: Design preferences (rankings); 'purchasing' decisions from designated budgets. Results  Eighty-five participants (49 men) tested products, 75 completed the shopping experiment. Inserts, most frequently supplied by the NHS, were ranked second to pull-ups by women and lowest by men. When faced with budget constraints, up to 40% of participants opted to 'mix-and-match' designs. Over 15 different combinations of products were selected by participants in the shopping experiment. Most (91%) stated a willingness to 'top-up' assigned budgets from income to secure preferred designs.

Discussion: Participants displayed diverse preferences. Enabling user choice of absorbent product design through individual budgets could improve satisfaction of consumers and efficiency of allocation of limited NHS resources.

Conclusion: Recent policy for the NHS seeks to provide consumers with more control in their care. Extension of the concept of individual budgets to continence supplies could be feasible and beneficial for patients and provide better value-for-money within the NHS. Further research is warranted.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5060721PMC
http://dx.doi.org/10.1111/j.1369-7625.2011.00750.xDOI Listing

Publication Analysis

Top Keywords

individual budgets
12
british national
8
national health
8
health service
8
urinary incontinence
8
shopping experiment
8
participants
6
products
5
nhs
5
budgets people
4

Similar Publications

Pharmacists are highly accessible healthcare professionals with presence in communities, hospitals, and clinics. They are well positioned to expand their roles in supporting individuals with mental health challenges. A cross-sectional study was conducted to identify trends in how pharmacists assess, monitor, identify, and care for patients with mental health challenges.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Background: It remains unclear to what extent global cognition translates to everyday functioning, although this is essential to interpreting the clinical meaningfulness of cognitive deficits. Here, we investigate potential linking between the Mini-Mental State Examination (MMSE) and the proxy-based Amsterdam Instrumental Activities of Daily Living Questionnaire (A-IADL-Q).

Methods: Cross-sectional data from 1228 amyloid-positive participants (age = 64±7yrs; 51.

View Article and Find Full Text PDF

Phasor-FSTM: a new paradigm for multicolor super-resolution imaging of living cells based on fluorescence modulation and lifetime multiplexing.

Light Sci Appl

January 2025

Center for Biomedical Optics and Photonics & College of Physics and Optoelectronic Engineering, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen, 518060, China.

Multicolor microscopy and super-resolution optical microscopy are two widely used techniques that greatly enhance the ability to distinguish and resolve structures in cellular imaging. These methods have individually transformed cellular imaging by allowing detailed visualization of cellular and subcellular structures, as well as organelle interactions. However, integrating multicolor and super-resolution microscopy into a single method remains challenging due to issues like spectral overlap, crosstalk, photobleaching, phototoxicity, and technical complexity.

View Article and Find Full Text PDF

Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States.

J Manag Care Spec Pharm

January 2025

Global Value and Real-World Evidence, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ.

Background: Bipolar disorder is a severe recurrent, episodic psychiatric condition with a worldwide prevalence of approximately 1%, affecting more than 5 million adults in the United States in 2020. A subtype, bipolar I disorder (BP-I), which accounts for approximately one-quarter of cases, is associated with impairments in psychosocial functioning and quality of life. Recommended treatment options include daily oral, or long-acting injectable, antipsychotics, including the aripiprazole once every month formulation, which has been shown to improve adherence compared with oral treatments.

View Article and Find Full Text PDF

Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with schizophrenia in the United States.

J Manag Care Spec Pharm

January 2025

Global Value and Real-World Evidence, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ.

Background: Schizophrenia is a chronic psychiatric disorder, affecting 1.1% of the adult population in 2020 in the United States. Antipsychotic treatment is commonly used in schizophrenia management to help reduce the likelihood of symptom recurrence and relapse.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!